Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 29;12(17):5636.
doi: 10.3390/jcm12175636.

Testicular Metastasis from Renal Cell Carcinoma: A Systematic Review

Affiliations
Review

Testicular Metastasis from Renal Cell Carcinoma: A Systematic Review

Anna Pliszka et al. J Clin Med. .

Abstract

Approximately one-third of renal cell carcinoma (RCC) is recognized in its metastatic stage. This systematic review aimed to summarize knowledge on the occurrence and treatment of testicular RCC metastasis. The literature search was performed by two authors independently, with the use of main electronic medical databases (Science Direct, Web of Science, and PubMed) until March 2023 to identify relevant articles that could potentially contribute to this review. Neither language nor publication dates were set as limits. Although we found a total of 51 case reports, only 31 of them contained all the required information. Testicular metastasis in patients with RCC suggests a late stage of the disease. Moreover, it usually does not present typical systemic or specific symptoms except for swelling and enlargement of the affected testis. Knowledge of the possibility of such variants of RCC metastases will allow a clinician to make an appropriate diagnosis and implement adequate treatment without delay, which is crucial in the management of neoplastic disease.

Keywords: neoplasm metastasis; renal cell carcinoma; testicular tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart.
Figure 2
Figure 2
Distribution of age at diagnosis of testicular mRCC between patients with testicular metastases as the first clinical manifestation of RCC and patients without testicular metastases as the first clinical manifestation of RCC.
Figure 3
Figure 3
Distribution of time between diagnosis of primary kidney tumor and testicular metastasis in months by T stage of primary RCC site in kidney with the results of the differences between the groups (the pT4 group with fewer than two data points has been omitted).

References

    1. Capitanio U., Bensalah K., Bex A., Boorjian S.A., Bray F., Coleman J., Gore J.L., Sun M., Wood C., Russo P. Epidemiology of Renal Cell Carcinoma. Eur. Urol. 2019;75:74–84. doi: 10.1016/j.eururo.2018.08.036. - DOI - PMC - PubMed
    1. Marzouk K., Alyami F., Merrimen J., Bagnell S. Metastatic renal cell carcinoma to the testis: A case report and review of the literature. Can. Urol. Assoc. J. 2014;8:924–927. doi: 10.5489/cuaj.2209. - DOI - PMC - PubMed
    1. Mori K., Mostafaei H., Miura N., Karakiewicz P.I., Luzzago S., Schmidinger M., Bruchbacher A., Pradere B., Egawa S., Shariat S.F. Systemic therapy for metastatic renal cell carcinoma in the first-line setting: A systematic review and network meta-analysis. Cancer Immunol. Immunother. 2021;70:265–273. doi: 10.1007/s00262-020-02684-8. - DOI - PMC - PubMed
    1. Gill D.M., Hahn A.W., Hale P., Maughan B.L. Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma. Curr. Treat. Options Oncol. 2018;19:6. doi: 10.1007/s11864-018-0517-1. - DOI - PubMed
    1. Posadas E.M., Limvorasak S., Figlin R.A. Targeted therapies for renal cell carcinoma. Nat. Rev. Nephrol. 2017;13:496–511. doi: 10.1038/nrneph.2017.82. - DOI - PubMed

LinkOut - more resources